Background: Capecitabine is a chemotherapeutic agent widely used for the treatment of malignancies. Ocular disorders have been reported with capecitabine therapy. Hesperidin is a naturally occurring compound derived mainly from citrus fruits and has a wide range of pharmacological activities and a proposed role in combating many ocular diseases. Aim: To evaluate the potential protective role of hesperidin against the corneal toxicity caused by capecitabine in adult male albino rats. Material and Methods: Thirty-six adult male albino rats were divided into four equal groups; control group, hesperidintreated group (50 mg/kg), capecitabine-treated group (40 mg/kg), and combination-treated "capecitabine and hesperidintreated" group. Animals were orally administered once daily for one month. Specimens from the cornea were processed for light and electron microscopy. Immunohistochemical study was performed using antibodies against p53. Results: Specimens from capecitabine-treated animals showed significant decrease of epithelial thickness. The corneal epithelial cells showed nuclear alteration and vacuolated cytoplasm. The stromal collagen fibers were irregularlyarranged and widely separated with neovascularization and mononuclear cellular infiltration. Ultrastructurally, focal widening of the intercellular spaces, partial loss of desmosomal junctions and swollen mitochondria were observed. The immunohistochemical study showed a significant increase in p53 immunoreaction. In contrast, minimal changes were observed in rats treated concomitantly with both capecitabine and hesperidin, with a non significant increase in the immunoreactions. Conclusion: Capecitabine induced structural changes in cornea of adult albino rat that could be ameliorated by concomitant treatment with hesperidin.
INTRODUCTION
The most widely used chemotherapeutic drugs associate with broad spectrum organ toxicities as bone marrow suppression, cardiac, pulmonary, gastrointestinal, hepatic, and renal toxicities, but the eye was considered a protected site [1] . Nonetheless, the ocular system is highly sensitive to toxic substances [2, 3] , and the systemic druginduced ocular side effects have been increased with the increasing numbers of new drugs being introduced [4] .
Ocular complications such as conjunctivitis, keratitis, cataract, macular edema, retinopathy and optic neuropathy have been associated with a variety of chemotherapeutic agents such as alkylating agents, anti-metabolites, taxanes and platinum agents [5, 6] .
Capecitabine (a fluoropyrimidine carbamate) is a proanticancer and immunosuppressive drug. Inside the body, it is enzymatically converted into 5-fluorouracil (5-FU) with high tumor selectivity [7, 8] . The improved tolerability and efficacy of capecitabine compared with intravenous 5-FU, in addition to its oral route of administration make it the best choice for different classes of carcinomas as colorectal, breast and pancreatic carcinomas [9] [10] [11] . Diarrhea, hand-foot syndrome and oromandibular dystonia are frequent complications for capecitabine treatment [12] [13] [14] . Moreover, ocular complications such as ocular irritation, decreased vision and corneal deposits have been associated with capecitabine therapy [15] .
Flavonoids are naturally occurring polyphenolic compounds synthesized by plants and having many pharmacological activities. They act as powerful free radical scavengers protecting the human body through the OH group present in their molecular structure. They include six major classes: flavonols, flavones, flavanones, catechins, anthocyanidins and isoflavones (16) .
Hesperidin is a natural inexpensive flavanone glycoside present in large quantities in citrus fruits like orange and lemon. It plays an important role in prevention of many diseases due to its anti-oxidant, anti-inflammatory, anticarcinogenic, anti-ulcer activities [17, 18] , in addition to its antimelanogenic and neuroprotective effects [19, 20] . Moreover, it has anti-microbial, anti-allergic, immunomodulatory, hepatoprotective, and nephroprotective effects [21] [22] [23] . The ameliorative role of hesperidin against tissue toxicities induced by various chemotherapeutic agents as doxorubicin, methotrexate, and cisplatin has been reported [24] [25] [26] .
Previous studies illustrated the therapeutic role of hesperidin in various ocular disorders such as diabetic retinopathy, diabetic macular edema in addition to its anti-cataractogenic effects [27] . Subsequently, we aimed to evaluate the potential protective role of hesperidin against the corneal toxicity caused by capecitabine in rats using different histological and immunohistochemical techniques.
MATERIALS AND METHODS:
Thirty-six adult male albino rats (180-200 grams) were used in this study. They were kept in clean properly ventilated cages under similar environmental conditions. One week prior to the experiment, all rats were kept in clean properly ventilated cages for acclimatization. A commercial balanced diet and tap water were provided throughout the experiment, with free access to food and water. The animals were kept on a 12-hour light/12-hour dark cycle before and throughout the study period. The experiment was approved by the local ethical Committee of Faculty of Medicine, Tanta University. The animals were divided into four equal groups (9 animals, each):
Group I (control group): It was subdivided into three equal subgroups; subgroup Ia received no treatment. Subgroup Ib received 0.5 ml of 0.25% solution of sodium carboxymethyl cellulose (the vehicle for hesperidin) orally once daily for one month. Subgroup Ic received 0.4 ml of normal saline solution (the vehicle for capecitabine) orally once daily for one month.
Group II (Hesperidin-treated group): Rats of this group were administered 0.5 ml of freshly prepared hesperidin (50 mg/kg) (28-30) dissolved in 0.25% solution of sodium carboxymethyl cellulose (CMC) orally by a gastric tube once daily for one month. Hesperidin was purchased from Sigma-Aldrich, St Louis, MO, USA (cat# H5254).
Group III (Capecitabine-treated group): Rats of this group were administered 40 mg/kg of capecitabine dissolved in 0.4 ml of normal saline solution orally by a gastric tube once daily for one month. The therapeutic dose of this drug for rat was calculated according to Paget and Barnes [31] . The chosen dose was nearly similar to the human effective therapeutic dose (ETD). Capecitabine (Xeloda) was purchased from Roche Company for pharmaceuticals (Cairo, Egypt) in the form of tablets containing 500 mg each.
Group IV (Capecitabine-& Hesperidin-treated group): Rats of this group were concomitantly administered both hesperidin and capecitabine (at the same doses and duration as in groups II &III, respectively).
At the end of the experiment, all rats were anesthetized by an intraperitoneal injection of pentobarbital (50 mg/ kg body weight) [32] . Then, the eyes were enucleated and the globes were placed in Karnovsky fixative (2% paraformaldehyde and 2.5% glutaraldehyde) for 24 hours. The cornea was excised from the remainder of the globe and processed for histological and immunohistochemical study.
For light microscopy: The specimens were immersed in 10% neutral-buffered formalin, washed, dehydrated, cleared and then embedded in paraffin. Sections of 5µm thickness were stained with haematoxylin and eosin (H&E) [33] .
For immunohistochemistry: 5μm thick sections were dewaxed, rehydrated, and washed with phosphate buffered saline (PBS). Then, the sections were incubated overnight in a humid chamber with the primary antibody (Rabbit polyclonal anti-rat antibody against p53 (Abcam, ab131442; Cambridge, Massachusetts, USA). The sections were incubated with diluted p53 primary antibody (1:100) in PBS overnight at 4°C. Thereafter, it was washed in PBS buffer, and co-incubated with biotinylated secondary antibody (Dako North America, Inc., CA, USA) for an hour at room temperature was performed. Streptavidin peroxidase was added for 10 minutes and rinsed three times in PBS. The immunoreactivity was visualized using 3, 3'diaminobenzidine (DAB)-hydrogen peroxide as a chromogen. Sections were counterstained with Mayer's haematoxylin. The negative control sections were prepared by excluding the primary antibodies [34] . Positive controls for p53 were MDA and JK cell extracts, HeLa cells and Human breast carcinoma tissue. The p53 immunostained corneal sections were considered positive upon expressing clear evident brown cytoplasmic and/or nuclear coloration.
For transmission electron microscopy: The specimens were fixed by immersion in 2.5 % phosphate buffered glutaraldehyde, processed and then embedded in epoxy resin by routine protocol. Semithin sections (1μm thick) were obtained and stained with 1% toluidine blue and examined by light microscope. Ultrathin sections (80-90nm) were stained with uranyl acetate and lead citrate to be examined by JEOL electron microscope at 80 KV in E.M unit, Faculty of Medicine, Tanta University [35] .
Morphometric study
Image analysis system (Leica Qwin 500 C Image analyzer computer system (Leica Imaging System LTD., Cambridge, England) at (Central Research Lab, Faculty of Medicine, Tanta University, Egypt) was used to measure:
1) The mean thickness of the corneal epithelium using H&E stained sections. Ten different non-overlapping randomly-selected fields at magnification of 100 were examined for each slide.
2) The mean color intensity of p53 positive immunohistochemical reaction (in DAB stained sections). Ten different non-overlapping randomly-selected fields at magnification of 400 were examined for each slide.
Statistical analysis
Data were analyzed by using one-way analysis of variance (ANOVA) followed by Tukey's test for comparison between the groups using statistical package for social sciences statistical analysis software (version 11.5; SPSS Inc., Chicago, Illinois, USA). All values were expressed as mean ± standard deviation. Differences were regarded as significant if probability value p< 0.05 and highly significant if p<0.001 [36] .
RESULTS
No deaths occur throughout the experimental period.
Light microscopic findings
Group I (control group): All control subgroups showed the same histological findings. H&E-stained sections of this group showed the characteristic histological structure of the cornea that was formed of five organized layers. The stratified squamous non keratinized epithelial layer appeared with its basal columnar cells, intermediate polygonal cells and superficial squamous cells. The corneal epithelium appeared resting on a uniform basement membrane underneath it was the Bowman's layer. The layer of corneal stroma (substantia propria) contained regularly arranged lamellae of collagen fibers that were parallel to each other. Flattened fibrocytes (keratocytes) were located between the lamellae of collagen fibers. Descemet's membrane layer appeared beneath the stroma and was covered by the inner endothelial layer (Fig. 1 ).
Group II (Hesperidin-treated group):
It showed the same histological structure as the control group.
Group
III (Capecitabine-treated group): Examination of H&E-stained sections of capecitabinetreated rats showed multifocal structural changes. The epithelium was mostly affected and focal areas of epithelial separation and desquamation were noticed (Fig. 2) . Some epithelial cells showed pale vacuolated cytoplasm and deeply stained nuclei (Fig. 3 ). In addition, apparent decrease in epithelial thickness was observed in some focal areas (Fig. 4) . Disruption and wide separation of the stromal fibers was observed (Figs. 3, 4) . Moreover, the anterior region of stroma close to the surface epithelium showed a neovascularization and inflammatory cellular infiltration (Figs. 2, 3 ). In addition, some endothelial cells showed pale vacuolated cytoplasm (Fig. 4) .
Group IV (capecitabine & hesperidin-treated group): H&E stained sections of this group revealed results almost similar to that of the control group. Nevertheless, cytoplasmic vacuolation was noticed in few epithelial cells (Fig. 5 ).
Immunohistochemical results:
P53-immunostained corneal sections of the control group I as well as the hesperidin-treated group II revealed moderate positive immunoreaction for p53 in corneal epithelial cells (Fig. 6a) . However, the stromal keratocytes and endothelium were negative for this reaction (Fig. 6b) . In capecitabine-treated group III, strong positive cytoplasmic and/or nuclear p53 immunoreactions was observed in many corneal epithelial cells, stromal keratocytes and endothelium (Figs. 7a, and 7b), while in capecitabine & hesperidin-treated group IV, moderate positive immunoreaction for p53 was detected in many corneal epithelial cells, and weak positive p53-immunoreaction was observed in the stromal keratocytes and endothelium (Figs. 8a, 8b ).
Electron microscopic results

Group I (control group):
Ultrathin sections revealed normal histological structure of the cornea. The corneal epithelium appeared to be formed of a basal layer of columnar cells with oval nuclei. The cytoplasm contained a profile of RER and mitochondria. The basal surface of these epithelial cells was in contact with the basement membrane by electrondense dotted hemidesmosomes. The intermediate cell layer were about 34-layers of polygonal cells having rounded nuclei. The squamous cells appeared superficially arranged in one or two layers and had flat nuclei. All these epithelial cells were attached together with numerous electron-dense desmosomes and had narrow intercellular spaces (Figs. 10, 11 ). The stroma composed of regular collagen fiber lamellae arranged parallel to the corneal surface. The keratocytes were spindle-shaped cells squeezed in-between these collagen lamellae, and contained electron-dense oval nuclei and scanty cytoplasm containing RER and lysosomes. Next to the stroma, a thick homogenous non-cellular electrondense lamina, Descemet's membrane, was found and appeared lined by a single flattened endothelial cell layer. The endothelial cells contained electron-dense flat elongated nuclei and a scanty cytoplasm with RER profile (Figs. 12, 13 ).
Group II (Hesperidin-treated group):
Electron microscopic findings of this group were similar to control group.
Group
III (Capecitabine-treated group): Examination of this group revealed marked ultrastructural changes in the cornea. The corneal epithelium showed focal separation and widening of the intercellular spaces with partial loss of desmosomal junctions (Fig. 14) . Cytoplasmic vacuolation as well as swollen mitochondria with disrupted cristae were found affecting most epithelial cell layers (Figs. 15-18 ). Some nuclei appeared with irregular outlines (Figs. 17, 18) , and others were shrunken and hyperchromatic (Figs. 16, 17) . Concerning the stroma, disorganized collagen fibers were observed in some specimens. In addition, cytoplasmic vacuolation and dilated RER were observed in some keratocytes (Fig. 19) . Another observation was the appearance of multiple variable sized vacuoles in the cytoplasm of some endothelial cells (Fig. 20 ).
Group IV: (capecitabine & hesperidin-treated group): Electron microscopic findings of this group were similar to control group. Nevertheless, mild cytoplasmic vacuolation and few swollen mitochondria were observed in few epithelial basal cells (Fig. 21) . Focal cytoplasmic vacuolation was observed in few intermediate and superficial cells (Fig. 22) . The stroma appeared almost normal (Fig. 23) . Few small vacuoles were observed in few endothelial cells (Fig. 24) .
Morphometric and statistical results
The mean color intensity of p53 positive immunoreaction in the capecitabine-treated group (group III) showed a significant increase (54 Mean thickness of the corneal epithelium Data are expressed as mean ± standard deviation, *P < 0.05 is significant versus control.
Histogram 1:
The mean color intensity of p53 positive immunoreaction in all groups.
Histogram 2:
The mean thickness of the corneal epithelium in all groups. (H&E X 400, InsetX1000). 
DISCUSSION
Chemotherapeutic drugs have a narrow therapeutic index with little difference between toxic and therapeutic effects, and the dosage needed to achieve a therapeutic response is usually toxic to different body systems and organs [37] . Many ocular disorders have been attributed to a number of anticancer drugs such as capecitabine [38] . These disorders are generally not preventable, therefore clinicians must be aware of the potential vision threatening complications caused by anticancer drugs [39] .
Many studies have reported the anti-inflammatory, antioxidant and anticarcinogenic effects of hesperidin. Moreover, hesperidin is essential for the treatment of many ocular disorders such as diabetic retinopathy and macular edema [40, 41] . Accordingly, this study aimed to evaluate the potential protective role of hesperidin against the corneal toxicity caused by the anticancer drug (capecitabine) in adult male albino rat employing different histological and immunohistochemical methods.
After reviewing light and electron microscopic results in this study, it could be demonstrated that 30 days treatment with capecitabine has altered the histological structure of the cornea and caused deformations especially in the epithelial layer that appeared desquamated. The remaining epithelium was vacuolar and degenerated having pyknotic nuclei. These results were similar to those induced by N-Ethyl-N-Nitrosourea (ENU) in mice treated with 600 mg/ kg group for 7 days [42] as well as to those induced by cisplatin treatment [43] . In addition, these results were consistent with the clinical results of some authors [15] who reported two cases having ocular irritation, decreased vision and corneal deposits associated with capecitabine use. Moreover, such corneal structural changes were consistent with the clinical findings in patients receiving other anticancer alkylating agents who complain of photophobia, foreign body sensation and tearing due to corneal epitheliopathy [44] .
The mechanism of action of capecitabine induced ocular toxicity is not wholly understood. In humans, the adverse effects of capecitabine vary greatly, and may be related to individual susceptibility, drug dosage or to enzymatic deficiencies [45] .
The present study could demonstrate corneal epithelial thinning that was confirmed by a highly significant decrease in the mean epithelial thickness in capecitabine-treated group as compared to control group. This was similar to the results of other researchers who studied the capecitabine induced corneal toxicity in dogs [46] . This epithelial thinning might be due to cellular degeneration and loss of dead cells with subsequent slow rate of cellular proliferation and regeneration [47] .
The corneal epithelium is the peripheral contact corneal region that is characterized by dynamic turnover due to continued proliferation of its basal epithelial cells which are displaced outward by the next generation of mitotic cells, and then, they are lost by desquamation [48] . The mechanisms that regulate corneal epithelial proliferation under normal physiological or pathological conditions are usually multifactorial and complex, and they are controlled by cytokine-receptor mediated events. Numerous cytokines such as epidermal growth factor activate receptors and cell signaling pathways that regulate this epithelial proliferation [49] .
Capecitabine is a 5-flurouracil (5-FU) prodrug, therefore, 5-FU shares the ocular toxicity with capecitabine. 5-FU treatment has been found to be associated with various types of ocular toxicity, affecting mainly the corneal epithelium [50] . Previous invitro studies on the human as well as rabbit corneal epithelial cells reported that 5-FU has anti-proliferative effects [51, 52] .
Wide spaces were observed between the collagen bundles in the stroma, and this indicates corneal edema. This was accompanied by a sign of inflammation in the form of mononuclear cellular infiltration in the anterior region of the stroma. This comes in agreement with the work of other researchers [53] . The stromal inflammatory cellular infiltration was reported to be due to release of interleukin 1β (IL1β) from the injured epithelial cells. IL1β is a multi-potent cytokine involved in acute inflammatory response leading to infiltration by various inflammatory cells as neutrophils and macrophages [54] .
Another observation was the corneal stromal neovascularizaion. Some investigators declared that the neovascularization could be secondary to inflammation [55] . The inflammation induced stromal edema proximal to the limbus allowed blood vessel growth from the limbus to the corneal stroma [56] . Moreover, others recorded that the epithelium of the basal layers of the cornea, endothelial cells and fibroblasts were the source of angiogenic factors such as vascular endothelial growth factor (VEGF) [57] .
The results of the present work could demonstrate that capecitabine induced apoptosis in the corneal epithelium as demonstrated by the histological results that showed pyknotic nuclei of the corneal epithelial cells. These findings were interpreted as apoptosis by some authors [58] . In addition, the immunohistochemical results of the present work could reveal that capecitabine induced apoptosis in corneal epithelium, endothelium and keratocytes through up-regulation of p53 protein expression as indicated by the significant increase in the color intensity of p53 positive immunoreaction in capecitabine-treated group as compared to control group. This was in agreement with recent invitro studies that illustrated that 5-FU induced apoptosis in cultured corneal epithelial and endothelial cells through upregulation of apoptosis-related proteins mainly p53, p21 and Bax [59, 60] . Other invitro study revealed that mitomycin C (an alkylating agent) induced apoptosis in cultured corneal keratocytes, and they attributed this to be due to the caspase cascade related to the mitochondrial pathway of apoptosis [61] .
P53 is a well known tumor suppressor protein that plays a key role in apoptosis [62] . P53 is normally synthesized in the cytoplasm and must transport into the nucleus to exert its transcriptional effect acting as a nuclear transcription factor that transactivates genes involved in apoptosis [63] . P53 can initiate apoptosis when DNA damage occurs [64] . Therefore, the significant up-regulation of p53 nuclear expression upon capecitabine administration in the present study could suggest the occurrence of DNA damage, and this may be suggested to be a mechanism of capecitabine induced corneal toxicity. This was in agreement with the results of other invitro study [65] that demonstrated a nuclear translocation of cytoplasmic p53 in rodent corneal epilthelial cells that occurred following ultraviolet (UV) exposure. In addition, the results of the present work revealed a significant up-regulation of p53 cytoplasmic expression upon capecitabine administration. Recent papers recorded the separate cytoplasmic role of p53 in directly regulating the Bax-dependent mitochondrial pathway to apoptotic cell death, as p53 rapidly translocates to the mitochondria inducing mitochondrial outer membrane permeabilization (MOMP), and triggering the release of pro-apoptotic factors [66] . On the other hand, the present study demonstrated a moderate expression of p53 in the cytoplasm of corneal epithelium of control rats, while the stromal keratocytes as well as endothelial cells were negative for this reaction. This result was identical to previous results noted in normal corneal epithelium in rats [67] , mice [68] and other vertebrates [69] , and this could be attributed to the high turnover rate of the normal corneal epithelium [68] .
At the protective level, hesperidin was introduced to examine its probable role in alleviating the capecitabine induced corneal toxicity. Results from this study clearly demonstrated that hesperidin offered an evident improvement in the corneal structural changes. This could be attributed to the antioxidant capacity of hesperidin as many studies reported that hesperidin enhanced the antioxidant defense mechanisms and reduced the oxidative stress [70, 71 & 72] . In addition, other studies proved that hesperidin is a hydrogen-donor and a free-radical scavenger [73] .
In this study, pretreatment with hesperidin decreased the inflammatory cellular infiltration. This antiinflammtory effect of hesperidin has been attributed to its effect on the prostaglandin synthesis and the cyclooxygenase-2(COX-2) pathway as reported by many invitro and invivo studies [74] .
In addition, hesperidin was found to be beneficial in ameliorating the degree of apoptotic cell death. This anti-apoptotic effect of hesperidin could be probably mediated through the suppression of p53-proteins as observed from the immunohistochemical results of the current work. Though, other investigators explained the anti-apoptotic activity of hesperidin to be through upregulation of Bcl-2 protein and suppression of Bax protein expression [75] .
Based on the previous results, the current study suggests that hesperidin might be beneficial in minimizing the capecitabine-induced corneal structural changes in rats most probably through its anti-inflammatory and anti-apoptotic effects. Therefore, hesperidin may be a useful therapeutic agent for the patient undergoing chemotherapeutic treatment with capecitabine drug to minimize its corneal complications.
